Dr Michel Pairet, Member of the Board of Managing Directors, Innovation Unit, Boehringer Ingelheim, discloses about the company’s strategic plans for both, global and the Indian markets, in an exclusive interaction with Sanjiv Das.
At the annual press conference in Ingelheim, several investments in China were announced. What is BI’s strategy when it comes to investing in India?
In 2017, Boehringer Ingelheim (BI) in India invested 125,000 euros in property, plant and equipment. BI India has a focused strategy of bringing its innovation-based research molecules to India to address evolving needs of the patients. Co-marketing partnerships have also played a major role in strengthening our presence and reaching a larger target audience.
The key focus for Boehringer Ingelheim India is diabetes, stroke, oncology and respiratory. Our launches over the last few years are Pradaxa (dabigatran for stroke prevention in atrial fibrillation) and Trajenta (linagliptin in diabetes) in 2012, Trajenta Duo (FDC of linagliptin and metformin) in 2014, followed by the launch of Xovoltib (afatinib) for NSCLC and co-marketing agreement with Lupin for the launch of 2nd brand of linagliptin and linagliptin-metformin under the brand names Ondero and Ondero Met respectively in 2015.
In 2016, we launched Jardiance (empagliflozin) in diabetes and had a strategic partnership with Lupin for the 2nd brand of empagliflozin, under the brand name Gibtulio. In 2017, Boehringer Ingelheim India entered the respiratory space with the launch of Cyendiv (nintedanib) for IPF (Idiopathic Pulmonary Fibrosis). This year saw the launch of FDCs Jardiance Met (empagliflozin-metformin) and Glyxambi (empagliflozin-linagliptin) as well as the expansion of our collaboration with Lupin for co-marketing of two oral antidiabetic drugs Gibtulio Met (empagliflozin – metformin) and Ajaduo (empagliflozinLinagliptin).
Diese Geschichte stammt aus der August 16-31, 2018-Ausgabe von Express Pharma.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der August 16-31, 2018-Ausgabe von Express Pharma.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation